Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
HIF1 activation safeguards cortical bone formation against impaired oxidative phosphorylation
Mohd P. Khan, … , Deanne Taylor, Ernestina Schipani
Mohd P. Khan, … , Deanne Taylor, Ernestina Schipani
Published August 1, 2024
Citation Information: JCI Insight. 2024;9(18):e182330. https://doi.org/10.1172/jci.insight.182330.
View: Text | PDF
Research Article Bone biology

HIF1 activation safeguards cortical bone formation against impaired oxidative phosphorylation

  • Text
  • PDF
Abstract

Energy metabolism, through pathways such as oxidative phosphorylation (OxPhos) and glycolysis, plays a pivotal role in cellular differentiation and function. Our study investigates the impact of OxPhos disruption in cortical bone development by deleting mitochondrial transcription factor A (TFAM). TFAM controls OxPhos by regulating the transcription of mitochondrial genes. The cortical bone, constituting the long bones’ rigid shell, is sheathed by the periosteum, a connective tissue layer populated with skeletal progenitors that spawn osteoblasts, the bone-forming cells. TFAM-deficient mice presented with thinner cortical bone, spontaneous midshaft fractures, and compromised periosteal cell bioenergetics, characterized by reduced ATP levels. Additionally, they exhibited an enlarged periosteal progenitor cell pool with impaired osteoblast differentiation. Increasing hypoxia-inducible factor 1a (HIF1) activity within periosteal cells substantially mitigated the detrimental effects induced by TFAM deletion. HIF1 is known to promote glycolysis in all cell types. Our findings underscore the indispensability of OxPhos for the proper accrual of cortical bone mass and indicate a compensatory mechanism between OxPhos and glycolysis in periosteal cells. The study opens new avenues for understanding the relationship between energy metabolism and skeletal health and suggests that modulating bioenergetic pathways may provide a therapeutic avenue for conditions characterized by bone fragility.

Authors

Mohd P. Khan, Elena Sabini, Katherine Beigel, Giulia Lanzolla, Brittany Laslow, Dian Wang, Christophe Merceron, Amato Giaccia, Fanxin Long, Deanne Taylor, Ernestina Schipani

×

Figure 7

HIF1dpA enhances expression of glycolytic enzymes and restores ATP levels in TFAM-deficient periosteal cells.

Options: View larger image (or click on image) Download as PowerPoint
HIF1dpA enhances expression of glycolytic enzymes and restores ATP level...
(A) UMAP visualization of aggregate clusters. (B) UMAP visualization of the mitochondrial marker ATP synthase subunit 6 (mt-Atp6), a downstream target of TFAM, and downstream targets of HIF1, including vascular endothelial growth factor A (Vegfa), Bcl2 interacting protein 3 (Bnip3), and prolyl-4-hydroxylase subunit alpha 1 (P4ha1). (C) UMAP analysis comparing the distribution of cells across clusters between CTRL (in orange) and TFAM HIF1dPA mutant (in light blue). (D) Nebulosa plots showing distribution of cells coexpressing skeletal progenitor markers — paired related homeobox 1 (Prx1), Thy-1 cell surface antigen (Cd90), platelet-derived growth factor receptor alpha (Pdgfra), stem cell antigen-1 (Sca1) — alongside osteoblast-like cell markers — bone gamma-carboxyglutamate protein (Bglap), alkaline phosphatase (Alpl). (E) Bar graph comparing percentage of periosteal cell subtypes in CTRL versus TFAM HIF1dPA, with cluster colors corresponding to UMAP distribution in A. (F) Violin plots showing increased expression of glycolytic markers in TFAM HIF1dPA mutant skeletal progenitors compared with CTRL, including hexokinase 2 (Hk2); phosphofructokinase, liver type (Pfkl); aldolase A (Aldoa); glyceraldehyde-3-phosphate dehydrogenase (Gapdh); phosphoglycerate kinase 1 (Pgk1); and lactate dehydrogenase A (Ldha). The data in the violin plots are shown as distributions, with the width of the plot representing the density of data points at different expression levels. (G) Violin plots illustrating increased expression of glycolytic markers in TFAM HIF1dPA mutant osteoblasts compared with CTRL. (H) Quantitative analysis of ATP in cultured CTRL and TFAM HIF1dPA periosteal cells. (I) Assessment of recombination efficiency at the ROSA26 locus in TFAM HIF1dPA and TFAM-floxed alleles. qPCR analysis of mitochondrial gene expression — cytochrome C oxidase 3 (Cox3), cytochrome B (Cytb), 16S ribosomal RNA (16S rRNA) — in CTRL and TFAM HIF1dPA mutant periosteal cells. Biological and technical duplicates were used in the analysis. scRNA-Seq data were analyzed using Wilcoxon’s signed-rank test. For ATP measurement, statistical significance was determined using either Wilcoxon’s matched pairs signed-rank test or an unpaired 2-tailed Student’s t test. Data were expressed as mean ± SD and normalized to CTRL levels. **P ≤ 0.01, ***P ≤ 0.001.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts